Skip to main content
OpenTrials

Clinical trial condition

Homozygous Familial Hypercholesterolemia

Explore clinical trials studying Homozygous Familial Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

57 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Homozygous Familial Hypercholesterolemia trial results

Completed

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

NCT03851705

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • (50852-001) Queen Mary Hospital Hong Kong
  • (50972-001) Hadassah Hospital Lipid Research Ein Kerem Jerusalem, Israel
  • (50007-001) Research Institute of Complex Issues of Cardiovascular Diseases Kemerovo, Russia
  • (50007-003) National Medical Research Centre of Cardiology Moscow, Russia
View all 13 locations
View Trial Details
Completed

Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

NCT03156621

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Regeneron Research Site Boca Raton, Florida, United States
  • Regeneron Research Site New York, United States
  • Regeneron Research Site Cincinnati, Ohio, United States
  • Regeneron Study Site Dallas, Texas, United States
View all 28 locations
View Trial Details
Completed

Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

NCT03399786

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Regeneron Research Site Boca Raton, Florida, United States
  • Regeneron Research Site Boston, Massachusetts, United States
  • Regeneron Research Site New York, United States
  • Regeneron Research Site Cincinnati, Ohio, United States
View all 30 locations
View Trial Details
Completed

Regeneron 1331 Kinetics Sub-Study HoFH

NCT04722068

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Department of Vascular Medicine Amsterdam UMC Amsterdam, AZ, Netherlands
View Trial Details
Completed

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

NCT03510715

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Investigational Site Number 0760001 São Paulo, Brazil
  • Investigational Site Number 1240001 Québec, Canada
  • Investigational Site Number 2080001 Viborg, Denmark
  • Investigational Site Number 4840006 Oaxaca City, Mexico
View Trial Details

Related conditions